	Treatment Patterns Among Androgen Receptor Pathway Inhibitor-Experienced Patients With Metastatic Castration-Resistant Prostate Cancer: A Global Real-World Study. Clin Genitourin Cancer von Amsberg G, Bulkley A, DeCongelio M, Skiles G, Grisolano J, Yang L, Masurkar N, Morasso C, Costanza-McDonald S, Yin X, Teitsson S, Patel MY, Narayan V. PMID: 41807148 [PubMed - as supplied by publisher]
	Comparison of the Prostate Imaging After Focal Ablation (PI-FAB) and Transatlantic Recommendations for Prostate Gland Evaluation (TARGET) for the Detection of In-Field Prostate Cancer Recurrence on Post-Focal Therapy Prostate Magnetic Resonance Imaging (MRI). Clin Genitourin Cancer Zhu D, Malshy K, Cheng Z, Mali K, Shen M, Bandari J, Hollenberg GM, Weinberg EP, Frye TP. PMID: 41807146 [PubMed - as supplied by publisher]
	Empirical evaluation of variability and multi-institutional generalizability of deep learning survival models: application to renal cancer CT scans. Comput Biol Med Flannery B, DeSilvio T, Hariri M, Sadri AR, Heller N, Weight C, Viswanath SE. PMID: 41806695 [PubMed - as supplied by publisher]
	In Vivo Target Drug Enrichment Based on Spatiotemporal Acoustic Node Modulation (STANM) for Bladder Cancer Treatment. Adv Mater Su Y, Wu J, Deng Z, Luo Y, Yin Q, Chen K, Liu X, Gao Q, Zhang W, Wang L, Ma Z, Zheng Y. PMID: 41806148 [PubMed - as supplied by publisher]
	HIF-2Î± Inhibitor Combinations Knock Back Kidney Cancer in Two Trials. Cancer Discov PMID: 41805886 [PubMed - as supplied by publisher]
	Multiphase CT-based deep learning radiomics nomogram models for preoperative WHO/ISUP grading of clear cell renal cell carcinoma: a two-center validation study. BMC Med Imaging Yang C, Zhang Z, Wu B, Zhao H, Ma T, Luo Y, Liao W, Yao X. PMID: 41803747 [PubMed - as supplied by publisher]
	Systematic Review of Genomic-Based Risk Stratification in Localised Prostate Cancer Treatment Optimisation: Clinical Impact and Health Economic Evidence. Cancer Med Lyu J, He F, Corcoran NM, Chen G, Akbarzadeh Khorshidi H. PMID: 41802997 [PubMed - indexed for MEDLINE]
	Dosimetric evaluation of biaxially rotational dynamic radiation therapy and swing-fixed non-coplanar volumetric modulated arc therapy with OXRAY in prostate cancer: a comparative study. Radiat Oncol J Hirotaki K, Makita K, Tomizawa K, Wakabayashi M, Hojo H, Nakamura M, Ito M. PMID: 41802420 [PubMed - as supplied by publisher]
	Impact of control selection strategies on GWAS results: a study of prostate cancer in the UK Biobank. Brief Bioinform Lu J, Thygesen JH, Beaumont RN, Weedon MN, Green HD. PMID: 41802281 [PubMed - indexed for MEDLINE]
	Comparison of Contrast-Enhanced Ultrasound and Enhanced MRI in Assessing the Depth of Invasion in Bladder Urothelial Carcinoma. Urol Int Dou Y, Chen X, Guo J, Wang H, Xiong Y, Zhao T. PMID: 41802145 [PubMed - as supplied by publisher]
	Predictive value of interim Â¹Â¹C-choline PET/CT for response to radium-223 in metastatic castration-resistant prostate cancer. EJNMMI Res Ahmed EE, Andrews JR, Ahmed ME, Haloi R, Rhodes LA, Mahon M, Carter DA, Wei N, Thorpe MP, Johnson GB, Kwon ED, Kendi AT. PMID: 41801523 [PubMed - as supplied by publisher]
	Scrotal uptake on PSMA PET in prostate cancer: differentiating metastases from benign and physiologic findings using ultrasound correlation. Abdom Radiol (NY) Takahashi H, Potretzke TA, Ehman EC, Lomas DJ, Alexander LF, Kwon ED, Kawashima A. PMID: 41801384 [PubMed - as supplied by publisher]
	Unusual metastatic patterns of urologic malignancies: a case series and literature review. Can J Urol Donmez K, Yorulmaz EM, Candemir E, Ozcan S, Kose O, Gorgel SN, Akin Y. PMID: 41800517 [PubMed - indexed for MEDLINE]
	Uretero-enteric strictures after cystectomy: revealing the modifiable risk factors. Can J Urol Akkad A, Bruyere F, Bourgi A. PMID: 41800511 [PubMed - indexed for MEDLINE]
	Artificial intelligence assisted 3D in the robotic urooncology? A systematic review and narrative synthesis of current applications, challenges and future directions. Can J Urol Barakat B, Al-Absi B, Hadaschik B, Rehme C, Schakaki S, Bauer J. PMID: 41800506 [PubMed - indexed for MEDLINE]
	Oncological outcomes of I125low dose brachytherapy in localized prostate cancer. Can J Urol Chéchile Toniolo G, Jornet N, Rojas J, Tejedor N, Carrara S, Maccagno A, Brufau T. PMID: 41800505 [PubMed - indexed for MEDLINE]
	PSMA PET/CT-guided pelvic lymph node dissection in patients with unfavorable intermediate- or high-risk prostate cancer. Can J Urol Donck E, Verbeke S, De Visschere P, Fonteyne V, Van Praet C, De Man K, Lumen N. PMID: 41800504 [PubMed - indexed for MEDLINE]
	Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospects. Can J Urol Zhan M, Zhou Z, Zhang J, Wang X, Li C, Pan B, Luo Z, Shi W, Wang Y, Li M, Wang W, Shi R, Zhu J. PMID: 41800500 [PubMed - indexed for MEDLINE]
	Prostate specific membrane antigen (PSMA) as a biomarker in early and localized advanced prostate cancer: a narrative review. Can J Urol Carll J, Bonaddio J, Woon D, Perera M, Lawrentschuk N, Chengodu T. PMID: 41800499 [PubMed - indexed for MEDLINE]
	Association between periodontal disease and prostatic disease: a systematic review and meta-analysis of observational studies. Can J Urol Li Q, Wu L, Zhang Y, Huang D, Ou-Yang S, Yang JY, Li BH, Zeng XT. PMID: 41800498 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 176648

Page 1 of 8833



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy